| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |